Total Payments
$191,276
2024 Payments
$38,778
Companies
72
Transactions
1,051
Medicare Patients
7,035
Medicare Billing
$1.8M
Payment Breakdown by Category
Other$122,522 (64.1%)
Food & Beverage$29,123 (15.2%)
Travel$19,558 (10.2%)
Consulting$18,451 (9.6%)
Education$1,623 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $62,205 | 22 | 32.5% |
| Honoraria | $60,317 | 35 | 31.5% |
| Food and Beverage | $29,123 | 914 | 15.2% |
| Travel and Lodging | $19,558 | 42 | 10.2% |
| Consulting Fee | $18,451 | 10 | 9.6% |
| Education | $1,623 | 28 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pharmacosmos Therapeutics Inc. | $73,270 | 93 | $0 (2024) |
| BeiGene USA, Inc. | $33,878 | 32 | $0 (2024) |
| SOBI, INC | $22,388 | 28 | $0 (2024) |
| Dova Pharmaceuticals | $14,771 | 16 | $0 (2021) |
| SHIELD THERAPEUTICS INC | $6,151 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $5,301 | 45 | $0 (2024) |
| Janssen Biotech, Inc. | $4,135 | 53 | $0 (2024) |
| Incyte Corporation | $3,823 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,918 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $2,862 | 90 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,778 | 163 | Pharmacosmos Therapeutics Inc. ($14,598) |
| 2023 | $65,481 | 220 | Pharmacosmos Therapeutics Inc. ($25,707) |
| 2022 | $28,316 | 180 | Sobi, Inc ($13,251) |
| 2021 | $44,742 | 116 | Pharmacosmos Therapeutics Inc. ($23,798) |
| 2020 | $3,862 | 98 | Dova Pharmaceuticals ($1,583) |
| 2019 | $4,752 | 116 | E.R. Squibb & Sons, L.L.C. ($699.43) |
| 2018 | $2,772 | 90 | PFIZER INC. ($261.42) |
| 2017 | $2,573 | 68 | E.R. Squibb & Sons, L.L.C. ($358.85) |
All Payment Transactions
1,051 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: Hematology | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.68 | General |
| 12/12/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $25.07 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $26.93 | General |
| Category: Hematology/Oncology | ||||||
| 11/26/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $34.92 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 11/19/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $31.13 | General |
| Category: Oncology | ||||||
| 11/08/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $120.19 | General |
| Category: Hematology | ||||||
| 11/07/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Honoraria | Cash or cash equivalent | $3,019.50 | General |
| Category: HEMATOLOGY | ||||||
| 11/07/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Travel and Lodging | Cash or cash equivalent | $48.11 | General |
| Category: HEMATOLOGY | ||||||
| 11/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $35.46 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $26.61 | General |
| 10/28/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug), TGCT | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: Oncology | ||||||
| 10/23/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/22/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: Oncology | ||||||
| 10/21/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 1,640 | 5,426 | $711,774 | $455,232 |
| 2022 | 9 | 1,551 | 4,979 | $659,294 | $415,737 |
| 2021 | 8 | 1,983 | 6,424 | $712,243 | $519,764 |
| 2020 | 8 | 1,861 | 5,999 | $609,886 | $450,008 |
Total Patients
7,035
Total Services
22,828
Medicare Billing
$1.8M
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 519 | 3,525 | $318,801 | $241,559 | 75.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 379 | 948 | $186,263 | $97,806 | 52.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 531 | 710 | $133,579 | $79,636 | 59.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 73 | 105 | $31,837 | $15,691 | 49.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 113 | 113 | $32,267 | $15,681 | 48.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $9,027 | $4,859 | 53.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 483 | 3,118 | $281,992 | $198,766 | 70.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 347 | 968 | $190,193 | $103,236 | 54.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 494 | 634 | $119,281 | $77,011 | 64.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 87 | 87 | $24,843 | $13,349 | 53.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 60 | 80 | $24,257 | $12,139 | 50.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $7,944 | $4,076 | 51.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 27 | $3,318 | $2,495 | 75.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 30 | $4,308 | $2,369 | 55.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $3,159 | $2,297 | 72.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 654 | 4,369 | $373,413 | $280,872 | 75.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 652 | 845 | $139,974 | $101,092 | 72.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 307 | 752 | $126,037 | $88,269 | 70.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 176 | 215 | $24,176 | $14,888 | 61.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 54 | 85 | $20,036 | $14,224 | 71.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 74 | 74 | $16,337 | $11,049 | 67.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 48 | 66 | $8,014 | $6,152 | 76.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $4,255 | $3,220 | 75.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 642 | 4,026 | $341,435 | $257,095 | 75.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 663 | 857 | $140,757 | $103,489 | 73.5% |
About Dr. Ilya Blokh, M.D
Dr. Ilya Blokh, M.D is a Hematology & Oncology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942253414.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ilya Blokh, M.D has received a total of $191,276 in payments from pharmaceutical and medical device companies, with $38,778 received in 2024. These payments were reported across 1,051 transactions from 72 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($62,205).
As a Medicare-enrolled provider, Blokh has provided services to 7,035 Medicare beneficiaries, totaling 22,828 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location Brooklyn, NY
- Active Since 05/18/2006
- Last Updated 08/15/2012
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1942253414
Products in Payments
- MONOFERRIC (Drug) $49,400
- BRUKINSA (Drug) $33,053
- Monoferric (Drug) $23,798
- Doptelet (Drug) $20,860
- DOPTELET (Drug) $16,294
- ACCRUFER (Drug) $6,151
- DARZALEX (Biological) $3,238
- BLENREP (Biological) $2,770
- CALQUENCE (Drug) $2,728
- CABOMETYX (Drug) $2,237
- TAGRISSO (Drug) $1,937
- ELIQUIS (Drug) $1,821
- XPOVIO (Drug) $1,690
- KEYTRUDA (Biological) $1,137
- OPDIVO (Biological) $865.02
- ERLEADA (Drug) $675.12
- LIBTAYO (Biological) $623.57
- IBRANCE (Drug) $577.24
- FOUNDATIONONE (Device) $473.92
- Kcentra (Biological) $462.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Brooklyn
Perry Cook, M.d, M.D
Hematology & Oncology — Payments: $1.4M
Hematology & Oncology $1.4M
Yiwu Huang, Md, MD
Hematology & Oncology — Payments: $268,275
Hematology & Oncology $268,275
Songchuan Guo, M.d, M.D
Hematology & Oncology — Payments: $106,907
Hematology & Oncology $106,907
Yiqing Xu, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $51,145
Hematology & Oncology $51,145
Dr. Azriel Hirschfeld, M.d, M.D
Hematology & Oncology — Payments: $48,699
Hematology & Oncology $48,699
Yan Pronin, P.a, P.A
Hematology & Oncology — Payments: $47,040
Hematology & Oncology $47,040